CAD 0.03
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -794.1 Thousand CAD | -6.92% |
2022 | -742.73 Thousand CAD | 53.44% |
2021 | -1.59 Million CAD | -104.17% |
2020 | -781.39 Thousand CAD | -31.44% |
2019 | -594.49 Thousand CAD | -314.31% |
2018 | -143.48 Thousand CAD | 37.13% |
2017 | -228.21 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -644.51 Thousand CAD | 24.2% |
2024 Q1 | -850.26 Thousand CAD | -7.07% |
2023 Q3 | -921.38 Thousand CAD | -49.37% |
2023 FY | -794.1 Thousand CAD | -6.92% |
2023 Q4 | -794.1 Thousand CAD | 13.81% |
2023 Q2 | -616.84 Thousand CAD | 8.39% |
2023 Q1 | -673.36 Thousand CAD | 9.34% |
2022 Q3 | -981.29 Thousand CAD | 16.16% |
2022 FY | -742.73 Thousand CAD | 53.44% |
2022 Q1 | -1.43 Million CAD | 10.03% |
2022 Q2 | -1.17 Million CAD | 18.45% |
2022 Q4 | -742.73 Thousand CAD | 24.31% |
2021 Q2 | -1.83 Million CAD | 16.32% |
2021 Q1 | -2.19 Million CAD | -180.88% |
2021 Q4 | -1.59 Million CAD | -5.66% |
2021 Q3 | -1.5 Million CAD | 17.79% |
2021 FY | -1.59 Million CAD | -104.17% |
2020 Q1 | -603.38 Thousand CAD | -1.5% |
2020 FY | -781.39 Thousand CAD | -31.44% |
2020 Q4 | -781.39 Thousand CAD | -31.09% |
2020 Q3 | -596.09 Thousand CAD | 0.42% |
2020 Q2 | -598.62 Thousand CAD | 0.79% |
2019 FY | -594.49 Thousand CAD | -314.31% |
2019 Q1 | -201.14 Thousand CAD | -40.18% |
2019 Q2 | -551.75 Thousand CAD | -174.3% |
2019 Q4 | -594.49 Thousand CAD | -7.9% |
2019 Q3 | -550.97 Thousand CAD | 0.14% |
2018 FY | -143.48 Thousand CAD | 37.13% |
2018 Q1 | 228.21 Thousand CAD | 0.0% |
2018 Q4 | -143.48 Thousand CAD | 0.0% |
2017 FY | -228.21 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
AI/ML Innovations Inc. | -3732.00 CAD | -21178.162% |
Diagnamed Holdings Corp. | -606.96 Thousand CAD | -30.832% |
Pangenomic Health Inc. | 952.18 Thousand CAD | 183.398% |
Treatment.Com International Inc. | -273.39 Thousand CAD | -190.46% |
Unidoc Health Corp. | -324.03 Thousand CAD | -145.07% |